Dashboard
Manage Tickers

CVEOCiveo Corp

NYSE civeo.com


$ 28.48 $ 0.05 (0.18 %)    

Tuesday, 17-Sep-2024 15:46:20 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.68 $ -3.29 (-0.69 %)
DIA $ 416.52 $ -1.46 (-0.35 %)
SPY $ 562.05 $ -3.08 (-0.55 %)
TLT $ 100.90 $ -0.49 (-0.48 %)
GLD $ 237.32 $ -0.66 (-0.28 %)
$ 28.15
$ 28.42
$ 28.42 x 200
$ 28.51 x 100
$ 28.38 - $ 28.66
$ 17.25 - $ 28.75
106,104
na
404.54M
$ 1.24
$ 11.51
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-30-2024 06-30-2024 10-Q
2 04-26-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 10-27-2023 09-30-2023 10-Q
5 07-28-2023 06-30-2023 10-Q
6 04-28-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 10-28-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 04-29-2022 03-31-2022 10-Q
11 02-28-2022 12-31-2021 10-K
12 10-28-2021 09-30-2021 10-Q
13 07-30-2021 06-30-2021 10-Q
14 04-30-2021 03-31-2021 10-Q
15 02-26-2021 12-31-2020 10-K
16 10-28-2020 09-30-2020 10-Q
17 07-29-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-27-2020 12-31-2019 10-K
20 10-29-2019 09-30-2019 10-Q
21 07-29-2019 06-30-2019 10-Q
22 04-26-2019 03-31-2019 10-Q
23 02-27-2019 12-31-2018 10-K
24 10-31-2018 09-30-2018 10-Q
25 07-27-2018 06-30-2018 10-Q
26 04-27-2018 03-31-2018 10-Q
27 02-23-2018 12-31-2017 10-K
28 10-26-2017 09-30-2017 10-Q
29 07-28-2017 06-30-2017 10-Q
30 04-27-2017 03-31-2017 10-Q
31 02-23-2017 12-31-2016 10-K
32 10-31-2016 09-30-2016 10-Q
33 07-29-2016 06-30-2016 10-Q
34 04-28-2016 03-31-2016 10-Q
35 02-26-2016 12-31-2015 10-K
36 11-03-2015 09-30-2015 10-Q
37 07-31-2015 06-30-2015 10-Q
38 04-30-2015 03-31-2015 10-Q
39 03-13-2015 12-31-2014 10-K
40 11-06-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

reported-earlier-civeo-renews-share-repurchase-authorization-for-up-to-5-of-outstanding-shares
Reported Earlier, Civeo Renews Share Repur...
09/12/2024 08:25:41

Civeo announced today that its Board of Directors has renewed its share repurchase authorization for the Company to repurchas...

top-3-industrials-stocks-that-may-implode-in-q3
Top 3 Industrials Stocks That May Implode ...
08/15/2024 12:31:38

civeo-corporation-announces-amendment-and-extension-to-its-credit-agreement-upsizing-total-revolving-credit-facility-capacity-from-200m-to-245m
Civeo Corporation Announces Amendment And ...
08/13/2024 20:34:58

stifel-reiterates-buy-on-civeo-raises-price-target-to-32
Stifel Reiterates Buy on Civeo, Raises Pri...
07/31/2024 15:30:52

Stifel analyst Stephen Gengaro reiterates Civeo (NYSE:CVEO) with a Buy and raises the price target from $31 to $32.

civeo-is-maintaining-previously-provided-fy24-revenue-guidance-range-of-625m-700m-vs-66518m-estimate
Civeo Is Maintaining Previously Provided F...
07/30/2024 10:36:19

For the full year of 2024, Civeo is maintaining its previously provided revenue and Adjusted EBITDA guidance ranges of $625 mil...

civeo-q2-gaap-eps-056-beats-021-estimate-sales-18871m-beat-17370m-estimate
Civeo Q2 GAAP EPS $0.56 Beats $0.21 Estima...
07/30/2024 10:33:05

Civeo (NYSE:CVEO) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.21 by 166.67 p...

civeo-appoints-andrew-andy-s-fraser-as-president-canada-effective-august-19-2024
Civeo Appoints Andrew "Andy" S. Fraser As ...
07/02/2024 20:34:27

Fraser brings extensive U.S., Canadian and international executive management experienceAl Schoening to retire after 13-year ca...

civeo-corporation-announced-the-appointment-of-e-collin-gerry-as-the-new-senior-vice-president-chief-financial-officer-and-treasurer-effective-august-1-2024-replacing-the-interim-ceo-barclay-brewer
Civeo Corporation Announced The Appointmen...
06/12/2024 10:31:36

stifel-maintains-buy-on-civeo-raises-price-target-to-31
Stifel Maintains Buy on Civeo, Raises Pric...
04/30/2024 11:23:34

Stifel analyst Stephen Gengaro maintains Civeo (NYSE:CVEO) with a Buy and raises the price target from $30 to $31.

Core News & Articles
Why Clever Leaves Holdings Shares Are Trad...
04/29/2024 17:04:01

civeo-maintains-fy24-revenue-guidance-range-of-625m-700m-est-653562m
Civeo Maintains FY24 Revenue Guidance Rang...
04/26/2024 10:34:34

For the full year of 2024, Civeo is maintaining its previously provided Adjusted EBITDA guidance range of $80 million to $90 mi...

civeo-q1-2024-gaap-eps-035-misses-020-estimate-sales-166120m-beat-154726m-estimate
Civeo Q1 2024 GAAP EPS $(0.35) Misses $(0....
04/26/2024 10:32:15

Civeo (NYSE:CVEO) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.20) by 75 p...

civeo-expects-fy24-revenues-of-625m-700m-vs-62311m-estimate-sees-adjusted-ebitda-of-80m-90m-and-capital-expenditures-of-30m-35m
Civeo Expects FY24 Revenues Of $625M-$700M...
02/29/2024 11:40:32

civeo-q4-sales-17080m-beat-15112m-estimate-company-exits-q4-with-cash-and-equivalents-worth-332m
Civeo Q4 Sales $170.80M Beat $151.12M Esti...
02/29/2024 11:37:51

Civeo (NYSE:CVEO) reported quarterly sales of $170.80 million which beat the analyst consensus estimate of $151.12 million by 1...

earnings-scheduled-for-february-29-2024
Earnings Scheduled For February 29, 2024
02/29/2024 10:15:24

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

earnings-outlook-for-civeo
Earnings Outlook For Civeo
02/28/2024 17:01:51

Core News & Articles
Matthews International Continues Support t...
02/19/2024 15:05:14

As the day concludes, Matthews International (NASDAQ:MATW) is preparing to distribute a dividend payout of $0.24 per share, res...

Core News & Articles
Matthews International Adapts to Economic ...
12/11/2023 15:05:24

stifel-maintains-buy-on-civeo-lowers-price-target-to-30
Stifel Maintains Buy on Civeo, Lowers Pric...
10/30/2023 15:04:47

Stifel analyst Stephen Gengaro maintains Civeo (NYSE:CVEO) with a Buy and lowers the price target from $31 to $30.

civeo-expects-adjusted-ebitda-of-95m-100m-compared-to-prior-guidance-of-90m-95m
Civeo Expects Adjusted EBITDA Of $95M-$100...
10/27/2023 10:44:56

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION